Dimenhydrinate

Catalog No.S4672

For research use only.

Dimenhydrinate is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.

Dimenhydrinate Chemical Structure

CAS No. 523-87-5

Purity & Quality Control

Choose Selective Histamine Receptor Inhibitors

Other Histamine Receptor Products

Biological Activity

Description Dimenhydrinate is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 469.96
Formula

C24H28ClN5O3

CAS No. 523-87-5
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.CN3C(=O)N(C)C4=C([NH]C(=N4)Cl)C3=O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04947423 Completed Drug: DPI-386 Nasal Gel|Drug: Placebo Motion Sickness Repurposed Therapeutics Inc.|Defender Pharmaceuticals Inc. June 14 2021 Phase 3
NCT02253524 Completed Drug: Dimenhydrinate|Drug: Metoclopramide Nausea|Vomiting|Vertigo Pamukkale University November 2012 Phase 4

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dimenhydrinate | Dimenhydrinate ic50 | Dimenhydrinate price | Dimenhydrinate cost | Dimenhydrinate solubility dmso | Dimenhydrinate purchase | Dimenhydrinate manufacturer | Dimenhydrinate research buy | Dimenhydrinate order | Dimenhydrinate mouse | Dimenhydrinate chemical structure | Dimenhydrinate mw | Dimenhydrinate molecular weight | Dimenhydrinate datasheet | Dimenhydrinate supplier | Dimenhydrinate in vitro | Dimenhydrinate cell line | Dimenhydrinate concentration | Dimenhydrinate nmr